Bayer AG (BAYN) is trading around €44.80 in Thursday’s European session, moving within an intraday range of approximately €43.95–€45.70 on Capital.com’s price feed as of 4:31pm UTC on 5 February 2026. Past performance is not a reliable indicator of future results.

The stock is trading as investors focus on upcoming catalysts, including Bayer’s planned publication of fourth-quarter and full-year 2025 results on 24 February 2026 and an analyst conference on 25 February 2026. These events are expected to provide additional detail on performance across its Pharmaceuticals, Consumer Health and Crop Science divisions (The Globe and Mail, 18 November 2025). Market attention is also on clinical developments, with Bayer scheduled…